SoulBio
Bengaluru, India· Est.
AI‑powered bioinformatics platform accelerating preclinical drug discovery for pharma and biotech.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
AI‑powered bioinformatics platform accelerating preclinical drug discovery for pharma and biotech.
OncologyImmunology
Technology Platform
AI‑powered multi‑omics pipelines that integrate public and proprietary datasets using deep‑learning models for target identification, biomarker discovery, and drug‑repurposing.
Opportunities
Expanding AI‑driven drug discovery services in emerging markets and forming strategic alliances with pharma to embed analytics into early‑stage pipelines.
Risk Factors
Dependence on high‑quality data, regulatory scrutiny of AI predictions, and competition from well‑funded global AI biotech firms.
Competitive Landscape
Competes with AI drug discovery platforms such as Insilico Medicine, BenevolentAI, and Exscientia, differentiating through a focus on customizable multi‑omics pipelines and Indian market expertise.